SECONDARY HYPERPARATHYROIDISM AMONG END-STAGE RENAL DISEASE PATIENTS

The role of secondary hyperparathyroidism in anemia of end stage renal disease

Introduction: secondary hyperparathyroidism is listed among the possible reasons for intensifying the anemia and resistance to erythropoietin therapy in hemodialysis patients. Although its exact mechanism is not entirely clarified, but shift of bone marrow cells to adipocytes, bone marrow fibrosis and decreased calciteriol can be the causes. However, the role of secondary hyperparathyroidism in...

Calcimimetic agents in the management of secondary hyperparathyroidism among patients with end-stage renal disease; a review article

Introduction End-stage renal disease (ESRD) is one of the most common life-threatening diseases with significant complication and poor outcomes (1-8). Possibly because of increasing prevalence of obesity, diabetes and hypertension, the number of ESRD patients increases each year and imposes a major social and economic burden on countries (9,10). Secondary hyperparathyroidism (SHPT) is a wellrec...

Utilization of parathyroidectomy for secondary hyperparathyroidism in end-stage renal disease

BACKGROUND The utilization of parathyroidectomy (PTX) to manage secondary hyperparathyroidism (SHPT) refractory to medical management (MTX) in end-stage renal disease (ESRD) in the era of calcimimetics is not well known. METHODS Adult ESRD patients receiving dialysis between August 2007 and December 2011 at our institution with an intact parathyroid hormone (iPTH) level ≥88 pmol/L for 6 month...

Massive soft tissue calcifications in severe hyperparathyroidism secondary to end-stage renal disease.

191 A 57‐year‐old woman with chronic kidney disease (CKD) on hemodialysis for 5 years underwent sub‐ total parathyroidectomy for secondary hyperpara‐ thyroidism. Three years later, she presented with gradually increasing serum parathormone (abo‐ ve 1000 pg/ml) and phosphate levels despite tre‐ atment with high doses of phosphate binders with active vitamin D metabolites. Simultaneously, bone pa...

Dyspepsia — An Underestimated Problem among End- stage Renal Disease Patients